Final-Program-ATS-2023-AP.vp

330

WEDNESDAY • MAY 24

CLINICAL PEDIATRIC CLINICAL CORE CURRICULUM

MEET THE EXPERT SEMINARS CME Credits Available: 1

CME Credits Available: 1 MOC Points Available: 1

R Pre-registration and additional fees required. Attendance is limited. $100 Member/Non-Members $70 LMIC Member/LMIC Non-Members. 11:00 a.m. - 12:00 p.m. Marriott Marquis Washington MTE54 UNDERSTANDING SEVERE AND STEROID-REFRACTORY IMMUNE CHECKPOINT INHIBITOR PNEUMONITIS K. Ho, MD, Columbus, OH J.D. Possick, MD, New Haven, CT University of DC/Catholic University (Level M1) MTE55 RUNNING AN EFFECTIVE INTERSTITIAL LUNG DISEASE MULTIDISCIPLINARY MEETING: REACHING THE GOLD STANDARD E. Valenzi, MD, Pittsburgh, PA C.T. Lee, MD, Chicago, IL Georgetown University (Level M1) MTE56 COMPLEX IN VITRO MODELS OF THE LUNG: BRIDGING THE GAP BETWEEN DISEASE COMPLEXITY AND THERAPEUTICS E.T. Osei, PhD, Kelowna, Canada J.K. Burgess, BSc, PhD, ATSF, Groningen, Netherlands M. Koenigshoff, MD, PhD, ATSF, Pittsburgh, PA Howard University (Level M1) MTE59 MOLECULAR DIAGNOSTICS IN SEVERE PNEUMONIA: THE EVIDENCE AND CASE-BASED DISCUSSION OF CLINICAL IMPLEMENTATION C. Pickens, MD, Chicago, IL R. Wunderink, MD, Chicago, IL LeDroit Park (Level M3) MTE60 EXTRACORPOREAL MEMBRANE OXYGENATION FOR CARDIAC ARREST: WHEN, WHY, AND HOW J. Tonna, MD, MS, Salt Lake City, UT M. Goodwin, MD, MS, FACS, Salt Lake City, UT Mount Vernon Square (Level M3) MTE61 FROM FEATHERS TO ANTIFIBROTICS: EXPOSURES, DIAGNOSIS, AND TREATMENT IN HYPERSENSITIVITY PNEUMONITIS B. Flashner, MD, Boston, MA Chinatown (Level M3)

PCC3 PEDIATRIC CLINICAL CORE CURRICULUM Education Committee 11:00 a.m. - 12:00 p.m. Target Audience Clinicians who are engaged in maintenance of certification activities Objectives At the conclusion of this session, the participant will be able to: • describe diagnosis and management of central and obstructive sleep disorders in infants • identify best practices for management and treatment of pulmonary hypertension in infants • describe best practices and standards of care for management of bronchopulmonary dysplasia in the neonatal intensive care unit and the post NICU period Chairing : J. Gross, MD, PhD, Denver, CO

C. Okorie, MD, Paulo Alto, CA M. McCown, MD, Bethesda, MD 11:00. Interstitial Lung Disease in Infants D. Ezmigna, MD, FAAP, Los Angeles, CA 11:25 Pulmonary Hypertension in Infants D. Bush, MD, NYC, NY 11:50 Questions and Answers

This session and the International Conference are supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. All CME sessions have been planned and implemented in accordance with the Accreditation Criteria of the Accreditation Council for Continuing Medical Education (ACCME®) and are free of the control of ineligible companies (formerly commercial interests).

ATS 2023 • Washington, DC